Internal Medicine, Infectious Disease · Jackson, MS
NPI
1891134011
Since 2013
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2500 N State St
Jackson, MS, 39216
Phone (601) 815-2005
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
280 services
Medicare patients, 2024
119
Average age 66
Drug cost, 2024
$616K
333 prescriptions
Company payments, 2025
$25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria X Bueno was code 99232 (hospital e&m - subsequent), 140 times for 62 patients. In total Maria X Bueno billed 280 services in 12 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 140 | 62 | $57.67 | $8,073 |
| 99223 Hospital E&M - Initial | Facility | 53 | 51 | $126.70 | $6,715 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 17 | $82.76 | $2,814 |
| 99214 Office E&M - Established | Facility | 22 | 16 | $67.92 | $1,494 |
By year: 2022 $39K for 452 services; 2023 $34K for 426 services; 2024 $21K for 280 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria X Bueno prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 63 prescriptions and refills. In total Maria X Bueno wrote 333 Medicare prescriptions that cost $616K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 63 | 63 | Under 11 | $237K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 | 46 | Under 11 | $134 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 23 | 23 | Under 11 | $105K |
| Valacyclovir Valacyclovir Hcl | 18 | 18 | Under 11 | $836 |
| Dovato Dolutegravir Sodium/Lamivudine | 16 | 16 | Under 11 | $42K |
| Juluca Dolutegravir/Rilpivirine | 12 | 12 | Under 11 | $37K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 12 | 12 | Under 11 | $52K |
| Ciprofloxacin Hcl Generic | 12 | 12 | Under 11 | $88.17 |
| Priftin Rifapentine | 12 | 12 | Under 11 | $1,277 |
| Isoniazid Generic | 11 | 11 | Under 11 | $26.52 |
| Tivicay Dolutegravir Sodium | 11 | 11 | Under 11 | $50K |
Brand drugs: 166 claims; generic drugs: 167 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria X Bueno $25 ($25 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $25.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.